Evaluation of biomarkers and surrogate endpoints in chronic disease /
"Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in ord...
Clasificación: | Libro Electrónico |
---|---|
Autor Corporativo: | |
Otros Autores: | , |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Washington, D.C. :
National Academies Press,
©2010.
|
Colección: | Online access: National Academy of Sciences National Academies Press.
Online access: NCBI NCBI Bookshelf. |
Temas: | |
Acceso en línea: | Texto completo |
MARC
LEADER | 00000cam a2200000 a 4500 | ||
---|---|---|---|
001 | EBOOKCENTRAL_ocn663886633 | ||
003 | OCoLC | ||
005 | 20240329122006.0 | ||
006 | m o d | ||
007 | cr cnu---unuuu | ||
008 | 100913s2010 dcua ob 000 0 eng d | ||
010 | |a 2010020157 | ||
040 | |a N$T |b eng |e pn |c N$T |d COF |d MERUC |d OCLCQ |d E7B |d IDEBK |d OCLCQ |d BUF |d OCLCQ |d YDXCP |d OCLCF |d OCLCQ |d NLGGC |d MMU |d CDX |d OCLCQ |d EBLCP |d OCLCQ |d AZK |d YDX |d VT2 |d AGLDB |d MOR |d PIFAG |d ZCU |d OCLCQ |d NJR |d OCLCQ |d OCLCO |d MERER |d OCLCO |d OCLCA |d U3W |d OCLCO |d OCLCQ |d CUY |d OCLCO |d OCLCQ |d STF |d VNS |d WRM |d OCLCQ |d VTS |d COCUF |d NRAMU |d EZ9 |d OCLCQ |d ICG |d OCLCQ |d OCLCO |d OCLCQ |d AU@ |d OCLCO |d OCLCQ |d WYU |d OCLCO |d S9I |d OCLCQ |d OCLCO |d OCLCQ |d DKC |d OCLCO |d OCLCQ |d M8D |d OCLCO |d OCLCQ |d OCLCO |d KIJ |d UKAHL |d OCLCQ |d OCLCA |d OCLCQ |d OCLCA |d VLY |d AJS |d LVT |d OCLCO |d DST |d OCLCO |d OCLCQ |d OCL |d OCLCO |d OCLCL |d OCLCQ |d OCLCL | ||
016 | 7 | |a 101530786 |2 DNLM | |
019 | |a 646841016 |a 676731306 |a 729024828 |a 764542771 |a 816590062 |a 923281847 |a 961530552 |a 962630291 |a 988456781 |a 992077003 |a 1021277643 |a 1028763782 |a 1037925515 |a 1038615052 |a 1045516110 |a 1047575334 |a 1048123908 |a 1055315790 |a 1064048525 |a 1081276864 |a 1119436423 |a 1119445521 |a 1162525587 |a 1229717324 |a 1243375892 |a 1290055767 |a 1300543660 | ||
020 | |a 9780309151306 |q (electronic bk.) | ||
020 | |a 0309151309 |q (electronic bk.) | ||
020 | |a 128278742X | ||
020 | |a 9781282787421 | ||
020 | |z 0309151295 |q (pbk.) | ||
020 | |z 9780309151290 |q (pbk.) | ||
020 | |a 9786612787423 | ||
020 | |a 6612787422 | ||
020 | |a 0309157277 | ||
020 | |a 9780309157278 | ||
024 | 8 | |a 9786612787423 | |
029 | 1 | |a AU@ |b 000051481230 | |
029 | 1 | |a DEBBG |b BV043134810 | |
029 | 1 | |a DEBBG |b BV044109077 | |
029 | 1 | |a DEBSZ |b 421688564 | |
029 | 1 | |a NZ1 |b 13866718 | |
035 | |a (OCoLC)663886633 |z (OCoLC)646841016 |z (OCoLC)676731306 |z (OCoLC)729024828 |z (OCoLC)764542771 |z (OCoLC)816590062 |z (OCoLC)923281847 |z (OCoLC)961530552 |z (OCoLC)962630291 |z (OCoLC)988456781 |z (OCoLC)992077003 |z (OCoLC)1021277643 |z (OCoLC)1028763782 |z (OCoLC)1037925515 |z (OCoLC)1038615052 |z (OCoLC)1045516110 |z (OCoLC)1047575334 |z (OCoLC)1048123908 |z (OCoLC)1055315790 |z (OCoLC)1064048525 |z (OCoLC)1081276864 |z (OCoLC)1119436423 |z (OCoLC)1119445521 |z (OCoLC)1162525587 |z (OCoLC)1229717324 |z (OCoLC)1243375892 |z (OCoLC)1290055767 |z (OCoLC)1300543660 | ||
037 | |a 278742 |b MIL | ||
050 | 4 | |a R853.B54 |b E93 2010eb | |
060 | 4 | |a QW 541 |b E917 2010 | |
072 | 7 | |a TEC |x 059000 |2 bisacsh | |
072 | 7 | |a MED |x 029000 |2 bisacsh | |
072 | 7 | |a MED |x 003040 |2 bisacsh | |
072 | 7 | |a MED |x 009000 |2 bisacsh | |
072 | 7 | |a MED |x 048000 |2 bisacsh | |
072 | 7 | |a MJC |2 bicssc | |
082 | 0 | 4 | |a 610.28 |2 22 |
049 | |a UAMI | ||
245 | 0 | 0 | |a Evaluation of biomarkers and surrogate endpoints in chronic disease / |c Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, Board on Health Care Services, Board on Health Sciences Policy, Food and Nutrition Board, Institute of Medicine ; Christine M. Micheel and John R. Ball, editors. |
260 | |a Washington, D.C. : |b National Academies Press, |c ©2010. | ||
300 | |a 1 online resource (xx, 314 pages) : |b illustrations | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
347 | |a data file |2 rda | ||
504 | |a Includes bibliographical references. | ||
505 | 0 | |a Review : evaluating and regulating biomarker use -- The biomarker evaluation process -- Case studies-- Strengthening evidence-based regulation. | |
520 | |a "Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process."--Publisher's description. | ||
588 | 0 | |a Print version record. | |
546 | |a English. | ||
590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
650 | 0 | |a Biochemical markers |x Evaluation. | |
650 | 0 | |a Chronic diseases. | |
650 | 0 | |a Biochemical markers. | |
650 | 0 | |a Evidence-based medicine. | |
650 | 2 | |a Biomarkers | |
650 | 2 | 2 | |a Chronic Disease |
650 | 2 | 2 | |a Evidence-Based Practice |
650 | 6 | |a Marqueurs biologiques |x Évaluation. | |
650 | 6 | |a Maladies chroniques. | |
650 | 6 | |a Marqueurs biologiques. | |
650 | 6 | |a Médecine factuelle. | |
650 | 7 | |a TECHNOLOGY & ENGINEERING |x Biomedical. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Family & General Practice. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Allied Health Services |x Medical Technology. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Biotechnology. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Lasers in Medicine. |2 bisacsh | |
650 | 7 | |a Evidence-based medicine |2 fast | |
650 | 7 | |a Biochemical markers |2 fast | |
650 | 7 | |a Biochemical markers |x Evaluation |2 fast | |
650 | 7 | |a Chronic diseases |2 fast | |
700 | 1 | |a Micheel, Christine. | |
700 | 1 | |a Ball, John, |d 1944- |1 https://id.oclc.org/worldcat/entity/E39PCjGgBTqTfqpTHwHCWp3683 | |
710 | 2 | |a Institute of Medicine (U.S.). |b Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease. | |
758 | |i has work: |a Evaluation of biomarkers and surrogate endpoints in chronic disease (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFDhy8gb8Xdx33tRhD6vpd |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
776 | 0 | 8 | |i Print version: |t Evaluation of biomarkers and surrogate endpoints in chronic disease. |d Washington, D.C. : National Academies Press, ©2010 |z 9780309151290 |w (DLC) 2010020157 |w (OCoLC)614271791 |
830 | 0 | |a Online access: National Academy of Sciences National Academies Press. | |
830 | 0 | |a Online access: NCBI NCBI Bookshelf. | |
856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378636 |z Texto completo |
938 | |a Askews and Holts Library Services |b ASKH |n AH36615353 | ||
938 | |a Askews and Holts Library Services |b ASKH |n AH36559245 | ||
938 | |a Coutts Information Services |b COUT |n 15486079 | ||
938 | |a ProQuest Ebook Central |b EBLB |n EBL3378636 | ||
938 | |a ebrary |b EBRY |n ebr10405099 | ||
938 | |a EBSCOhost |b EBSC |n 334327 | ||
938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 278742 | ||
938 | |a YBP Library Services |b YANK |n 3467269 | ||
994 | |a 92 |b IZTAP |